The current earnings forecast score of Hims & Hers Health Inc is 6.50, ranking 55 out of 75 in the Healthcare Providers & Services industry. The average price target is 41.00, with a high of 85.00 and a low of 30.00.
Analyst Rating
Based on
16
analysts
Hold
Current Rating
30.187
Target Price
-0.17%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
Hims & Hers Health Inc
HIMS
16
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Hims & Hers Health Inc's expected revenue for the next quarter?
Hims & Hers Health Inc's expected revenue is 699.89M.
What is Hims & Hers Health Inc's price target?
Analysts forecast that Hims & Hers Health Inc's price target is USD 41.00, with the highest forecast at USD 85.00 and the lowest forecast at USD 30.00.
How have Hims & Hers Health IncHIMS's recent earnings per share performed?
The market expectation was USD -0.40, while Hims & Hers Health IncHIMS's earnings per share (EPS) for the previous quarter was USD 0.09. EPS for the next quarter is expected at USD -0.01.
What is the analyst rating for Hims & Hers Health Inc?
Based on the ratings of Hims & Hers Health Inc's stock from 16 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.